BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2683681)

  • 1. Possible mechanisms underlying peripheral lymphocyte activation in chronic liver disease and asymptomatic HBsAg carriers.
    Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagra F
    Allergol Immunopathol (Madr); 1989; 17(3):145-8. PubMed ID: 2683681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated lymphocytes in the peripheral blood of asymptomatic HBsAg carriers.
    Raptopoulou-Gigi M
    APMIS; 1989 Feb; 97(2):190-2. PubMed ID: 2784060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers].
    Tian Y; Qiu ZF; Li TS
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3354-8. PubMed ID: 16409844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A, B, C and DR antigens in chronic hepatitis B viral infection.
    Yang PM; Sung JL; Chen DS
    Hepatogastroenterology; 1989 Oct; 36(5):363-6. PubMed ID: 2620904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.
    Barnaba V; Musca A; Cordova C; Levrero M; Ruocco G; Albertini-Petroni V; Balsano F
    Clin Exp Immunol; 1983 Aug; 53(2):281-8. PubMed ID: 6224609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte activation in chronic hepatitis B infection: interleukin 2 release and its receptor expression.
    Lai KN; Leung JC; Tam JS; Leung NW
    Am J Gastroenterol; 1989 Dec; 84(12):1532-7. PubMed ID: 2596455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous rosette-forming T cells and their relationship to OKT4+ and OKT8+ cells in chronic HBV infection.
    Victorino RM; Lucas M; de Moura MC
    J Clin Lab Immunol; 1986 Jul; 20(3):137-41. PubMed ID: 2943900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes.
    Barnaba V; Levrero M; Franco A; Zaccari C; Musca A; Balsano F
    J Clin Lab Immunol; 1985 Mar; 16(3):137-42. PubMed ID: 3162024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection.
    van Hattum J; van Oudenaren A; Schalm SW; Visser JW; Benner R
    Scand J Gastroenterol; 1984 Jun; 19(4):497-501. PubMed ID: 6611578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in T cell subsets and the expression of receptors of transferrin and interleukin-2 in chronic active hepatitis].
    Tang W
    Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):91-3, 128. PubMed ID: 1327441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of sub-populations of circulating T lymphocytes in alcoholic cirrhosis using monoclonal antibodies OKT3, 4, 5, Leu 2 and Leu 15. Effect of hepatitis B virus infection].
    Vetter D; Eichler F; Doffoël M; Krzisch C; Gut JP; Willemin B; Reville M; North ML; Keiling R; Bockel R
    Gastroenterol Clin Biol; 1987 Nov; 11(11):790-4. PubMed ID: 2962894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAg-induced antigen-specific T and B lymphocyte responses in chronic hepatitis B virus carriers and immune individuals.
    Fernan A; Cayzer CJ; Cooksley WG
    Clin Exp Immunol; 1989 May; 76(2):222-6. PubMed ID: 2788046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of hepatitis B surface antigen (HBsAg) induced interleukin-2 secretion in chronic asymptomatic carriers of HBsAg.
    Sylvan SP; Hekkström UB
    Clin Exp Immunol; 1989 Nov; 78(2):207-13. PubMed ID: 12412750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunology of liver diseases].
    Meyer zum Büschenfelde KH
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular and humoral immunity in asymptomatic carriers of the hepatitis B virus].
    Asfandiiarova NS; Fazylova SM; Tkalicheva LI; Dzhavatova LS
    Ter Arkh; 1984; 56(10):47-9. PubMed ID: 6523361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma receptors on T cells in patients with chronic liver disease.
    Kakumu S; Yoshioka K; Fuji A; Tahara H
    Hepatogastroenterology; 1988 Aug; 35(4):158-61. PubMed ID: 2972598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcoholic liver cirrhosis is associated with a decreased expression of the CD28 costimulatory molecule, a lower ability of T cells to bind exogenous IL-2, and increased soluble CD8 levels.
    Laso FJ; Iglesias-Osma C; Ciudad J; López A; Pastor I; Torres E; Orfao A
    Cytometry; 2000 Oct; 42(5):290-5. PubMed ID: 11025487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.